LuciusAlexanderHowellMD

PubMed

• 49 citations
  Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-guided Antiplatelet Therapy after Percutaneous Coronary Intervention
  Craig R. Lee, Vindhya B. Sriramoju, Alexandra Cervantes, Lucius A. Howell, Nicholas Varunok, Shivanshu Madan, Kasey Hamrick, Melissa J. Polasek, John Andrew Lee, Megan...> ;Circulation. Genomic and Precision Medicine. 2018 Apr 1
• 188 citations
  Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
  Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper-DeHoff, Julio D. Duarte, Deepak Voora, Stephen E. Kimmel, Caitrin W. McDonough, Yan Gong, Chi...> ;JACC. Cardiovascular Interventions. 2018 Jan 22
• 2 citations
  Relation of an Echocardiographic-Based Cardiac Calcium Score to Mitral Stenosis Severity and Coronary Artery Disease in Patients with Severe Aortic Stenosis.
  Siyuan P. Sheng, Lucius A. Howell, Melissa C. Caughey, Michael Yeung, John P. Vavalle> ;The American Journal of Cardiology. 2018 Jan 15
• 3 citations
  Review of clopidogrel dose escalation in the current era of potent P2Y12 inhibitors
  Lucius A. Howell, George A. Stouffer, Melissa J. Polasek, Joseph S. Rossi> ;Expert Review of Clinical Pharmacology. 2015 Jun 25
• 31 citations
  Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients.
  John Andrew Lee, Craig R. Lee, Brent N. Reed, David C. Plitt, Melissa J. Polasek, Lucius A. Howell, Jonathan D. Cicci, Kristen E Tasca, Karen E. Weck, Joseph S. Rossi,...> ;Pharmacogenomics. 2015 Mar 31
• Join now to see all